Skip to main content
. 2022 Jun 6;11(11):3239. doi: 10.3390/jcm11113239

Figure 5.

Figure 5

Forest plots and funnel plots for 14-day mortality between colistin monotherapy and colistin plus meropenem combination therapy. Five studies involving 949 patients (441 with colistin monotherapy, 508 with colistin plus meropenem combination therapy) reported 14-day mortality. There was no significant difference in 14-day mortality between patients treated with colistin monotherapy and colistin plus meropenem combination therapy [24,26,27,28,30].